Pramila Krishnamurthy
@drpramilak
Followers
1K
Following
5K
Media
32
Statuses
2K
Consultant in haematology, King’s College Hospital, London. AML, MDS and BMT. John Goldman Leukaemia UK Fellow 2021
Joined October 2009
RT @DavidSteensma: With the disappointing announcement today by @abbvie of the negative result of the VERONA venetoclax/azacitidine trial,….
0
79
0
RT @Dr_AmerZeidan: Long awaited results of #VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results….
0
42
0
RT @CureLeukaemia: Hear from Dr. Pramila Krishnamurthy at King’s College Hospital as she explains the crucial role of clinical trials in ad….
0
4
0
RT @CureLeukaemia: Say Hello to ATICUS! Supported by our patron Gary Lineker, this network funds potentially life-saving trials for childre….
0
16
0
RT @CureLeukaemia: Ever wondered why clinical trials matter? Because every day, they bring us closer to better treatments and hope for pati….
0
1
0
RT @CureLeukaemia: On #InternationalClinicalTrialsDay we're celebrating the life-saving difference clinical trials make through our funding….
0
6
0
RT @CureLeukaemia: Today, Kerry McNally Group Head of Communities at @FlutterEnt visited @KingsCollegeNHS to learn how their funding over t….
0
4
0
RT @EOCS_Official: 🔴 We strongly welcome the Public Accounts Committee Report on Remediation of Dangerous Cladding. We thank the @Commons….
0
50
0
RT @alex_tonks: Report calls for action to tackle decline in clinical researchers – UKRI. Critical in all aspects including bloodcancer re….
0
7
0
RT @andiroy: Preprint alert: this was a wonderful collaborative project with Prof Karadimitris @ImperialImmuno and many others. Thanks t….
0
7
0
RT @Ramikomrokji: Our most recent review in Blood . honored to work on this with the talented @dralainmina who put this together . https:/….
0
18
0
RT @ProfChrisPFox: Thank you @CureLeukaemia @Mc73James for your relentless focus & commitment on improving survival for patients with blood….
0
2
0
RT @doctorpemm: 👉👉👉Delighted to share our group’s new paper analyzing #TP53 impact & outcomes in patients with myeloid neoplasms 🚨 just out….
0
19
0
RT @MAF_Dawson: Thrilled to share a wonderful collaboration with @Armstrong_dfci @florian_perner @shellainasci !!. Catalytic inhibition of….
0
17
0
RT @jayastuMD: ➡️ Check out our paper on Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neo….
0
38
0
RT @dap_martins: Fantastic talk from Dr. Zheng from the @QuekLab on the role of TP53 mutations in CH-associated dyserythropoiesis and OxPho….
0
1
0
RT @sanamloghavi: Ending #ASH24 Sunday with a spectacular presentation on Black AML, highlighting the role of PHIP mutations in this pt po….
0
6
0
RT @ProfChrisPFox: Dr David Lewis 🇬🇧 presenting primary outcome data from the ENRICH RCT. Huge effort & important data @tobyeyre82 @Mark….
0
5
0